TR 701

Known as: TR-701, TR701 cpd 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2012
02420082012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Tedizolid (TR-700, formerly torezolid) is the active moiety of the prodrug tedizolid phosphate (TR-701), a next-generation… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Review
2012
Review
2012
INTRODUCTION Tedizolid phosphate (TR-701) is a new oxazolidinone prodrug that is transformed in the serum into the active drug… (More)
Is this relevant?
2012
2012
Plasma concentrations of antimicrobial drugs have long been used to correlate exposure with effect, yet one cannot always assume… (More)
Is this relevant?
2011
2011
Torezolid phosphate (TR-701) is the phosphate monoester prodrug of the oxazolidinone TR-700 which demonstrates potent in vitro… (More)
Is this relevant?
2011
2011
Tedizolid (TR-700, formerly torezolid) is the active component of the new oxazolidinone prodrug tedizolid phosphate (TR-701). We… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2010
2010
This study assessed the spectrum of activity of torezolid (TR-700), the active moiety of torezolid phosphate (TR-701), and… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
TR-700 (torezolid), the active moiety of the novel oxazolidinone phosphate prodrug TR-701, is highly potent against gram-positive… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2009
2009
TR-701 is the prodrug of the microbiologically active molecule TR-700, a novel orally and intravenously administered… (More)
Is this relevant?
2009
2009
BACKGROUND TR-700, the active component of the oxazolidinone prodrug TR-701, has demonstrated potent activity against numerous… (More)
Is this relevant?
2008
2008
TR-701 is the orally active prodrug of TR-700, a novel oxazolidinone that demonstrates four- to eightfold-greater activity than… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?